Association of GSTM1 Deletion With Progression of CKD in Children: Findings From the Chronic Kidney Disease in Children (CKiD) Study.

RATIONALE AND OBJECTIVE Loss of function of the product of the GSTM1 gene has been implicated in rapid progression of adult CKD. Its role in pediatric CKD has not been previously described. STUDY DESIGN The study is a secondary analysis of a prospective observational cohort examining the association between deletions in GSTM1 and progression of CKD. SETTING AND PARTICIPANTS We used data and samples from the prospective Chronic Kidney Disease in Children (CKiD) cohort aged 1-16 years at enrollment with CKD. EXPOSURE We defined exposure fewer than two GSTM1 alleles on real-time polymerase chain reaction amplification. OUTCOME The primary outcome was a composite of 50% decrease in estimated glomerular filtration rate (eGFR) or start of kidney replacement therapy. Secondary outcomes included remission of proteinuria in children with glomerular disease and cardiovascular complications. ANALYTIC APPROACH The primary analysis was by Cox proportional hazards model. Analysis was adjusted for age, sex, race, ethnicity, BMI category, diagnosis category, and eGFR. RESULTS 674 children were included in the analysis. Mean age at most recent visit was 11.9 years; 61% were male and 20% were Black. There were 241 occurrences of the primary outcome at the time of analysis. After adjustment for baseline characteristics, the risk of progression of CKD for exposed children was 1.94 (1.27, 2.97). The effect size was similar with either one or two deletions (autosomal dominant inheritance). The relationships between number of functional GSTM1 alleles and prespecified secondary outcomes were not statistically significant after adjustment. LIMITATIONS Missing data, especially for secondary outcomes, and relatively small sample size compared to genetic studies in adults. CONCLUSIONS GSTM1 deletion is associated with more rapid progression of pediatric CKD after adjustment in this large prospective cohort. No statistically significant associations were seen with secondary outcomes. If replicated, these findings may inform development of interventions for CKD in children.

[1]  Mina Matsuda-Abedini,et al.  Association of Time-Varying Blood Pressure With Chronic Kidney Disease Progression in Children , 2020, JAMA network open.

[2]  E. Boerwinkle,et al.  GSTM1 Deletion Exaggerates Kidney Injury in Experimental Mouse Models and Confers the Protective Effect of Cruciferous Vegetables in Mice and Humans. , 2019, Journal of the American Society of Nephrology : JASN.

[3]  E. Boerwinkle,et al.  The Loss of GSTM1 Associates with Kidney Failure and Heart Failure. , 2017, Journal of the American Society of Nephrology : JASN.

[4]  A. Webster,et al.  Chronic Kidney Disease , 2017, The Lancet.

[5]  Catherine C. Robertson,et al.  APOL1-associated glomerular disease among African-American children: a collaboration of the Chronic Kidney Disease in Children (CKiD) and Nephrotic Syndrome Study Network (NEPTUNE) cohorts , 2016, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[6]  C. Winkler,et al.  Combined Effects of GSTM1 Null Allele and APOL1 Renal Risk Alleles in CKD Progression in the African American Study of Kidney Disease and Hypertension Trial. , 2016, Journal of the American Society of Nephrology : JASN.

[7]  Craig S. Wong,et al.  Predictors of Rapid Progression of Glomerular and Nonglomerular Kidney Disease in Children and Adolescents: The Chronic Kidney Disease in Children (CKiD) Cohort. , 2015, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[8]  Association Between GSTM1 Null Genotype and Coronary Artery Disease Risk: A Meta-Analysis , 2014, Medical science monitor : international medical journal of experimental and clinical research.

[9]  B. Peterlin,et al.  GSTM1-null and GSTT1-null genotypes are associated with essential arterial hypertension in patients with type 2 diabetes. , 2014, Clinical biochemistry.

[10]  G. García-García,et al.  Contribution of GSTM1, GSTT1, and MTHFR polymorphisms to end-stage renal disease of unknown etiology in Mexicans , 2013, Indian journal of nephrology.

[11]  Quantitative assessment of the association between the GSTM1-null genotype and the risk of childhood asthma. , 2013, Genetic testing and molecular biomarkers.

[12]  C. Nievergelt,et al.  Loss of GSTM1, a NRF2 target, is associated with accelerated progression of hypertensive kidney disease in the African American Study of Kidney Disease (AASK). , 2013, American journal of physiology. Renal physiology.

[13]  Huirong Li,et al.  Effect of GSTM1 null genotype on risk of childhood acute leukemia: a meta-analysis , 2013, Tumor Biology.

[14]  Susan L. Furth,et al.  Improved equations estimating GFR in children with chronic kidney disease using an immunonephelometric determination of cystatin C , 2012, Kidney international.

[15]  A. Shinagawa,et al.  Evaluation of Hepatic Glutathione Transferase Mu 1 and Theta 1 Activities in Humans and Mice Using Genotype Information , 2012, Drug Metabolism and Disposition.

[16]  K. V. van Stralen,et al.  Epidemiology of chronic kidney disease in children , 2011, Pediatric Nephrology.

[17]  O. P. Kalra,et al.  Association of glutathione S-transferase M1 and T1 gene polymorphism with oxidative stress in diabetic and nondiabetic chronic kidney disease , 2010, Renal failure.

[18]  T. Le,et al.  Glutathione S-Transferase-&mgr;1 Regulates Vascular Smooth Muscle Cell Proliferation, Migration, and Oxidative Stress , 2009, HYPERTENSION.

[19]  Z. Massy,et al.  PROGRESS IN UREMIC TOXIN RESEARCH: The Role of Oxidative Stress in Chronic Kidney Disease , 2009, Seminars in dialysis.

[20]  J. Ioannidis,et al.  STrengthening the REporting of Genetic Association Studies (STREGA)— An Extension of the STROBE Statement , 2009, PLoS medicine.

[21]  J. Varni,et al.  Measuring health-related quality of life in children with ESRD: performance of the generic and ESRD-specific instrument of the Pediatric Quality of Life Inventory (PedsQL). , 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[22]  S. Agrawal,et al.  Relationship between GSTs Gene Polymorphism and Susceptibility to End Stage Renal Disease among North Indians , 2007, Renal failure.

[23]  Craig S. Wong,et al.  Design and methods of the Chronic Kidney Disease in Children (CKiD) prospective cohort study. , 2006, Clinical journal of the American Society of Nephrology : CJASN.

[24]  P. Kimmel,et al.  Trends in treatment and outcomes of survival of adolescents initiating end-stage renal disease care in the United States of America , 2006, Pediatric Nephrology.

[25]  J. Pankow,et al.  Risk of Atherosclerosis: Interaction of Smoking and Glutathione S-Transferase Genes , 2003 .

[26]  P. Vineis,et al.  Metabolic gene polymorphism frequencies in control populations. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[27]  H. Wollersheim,et al.  Effect of glutathione S-transferase M1 genotype on progression of atherosclerosis in lifelong male smokers. , 2001, Atherosclerosis.